280 related articles for article (PubMed ID: 3231355)
1. Identification and management of DES-exposed women.
Vieiralves-Wiltgen C; Engle VF
Nurse Pract; 1988 Nov; 13(11):15-6, 19-20, 22 passim. PubMed ID: 3231355
[TBL] [Abstract][Full Text] [Related]
2. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
[TBL] [Abstract][Full Text] [Related]
3. Management of the adolescent girl exposed in utero to DES.
Gerbie MV
Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
[TBL] [Abstract][Full Text] [Related]
4. The current status of the DES-exposed population.
Herbst AL
Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
[TBL] [Abstract][Full Text] [Related]
5. Diethylstilbestrol in pregnancy: an update.
Kinch RA
Can Med Assoc J; 1982 Nov; 127(9):812-3. PubMed ID: 7139494
[TBL] [Abstract][Full Text] [Related]
6. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
Barclay DL
J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
[TBL] [Abstract][Full Text] [Related]
7. Cervical and vaginal cancer detection at a regional diethylstilbestrol (DES) screening clinic.
Piver MS; Lele SB; Baker TR; Sandecki A
Cancer Detect Prev; 1988; 11(3-6):197-202. PubMed ID: 3390844
[TBL] [Abstract][Full Text] [Related]
8. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
Edelman DA
Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761
[TBL] [Abstract][Full Text] [Related]
9. DES exposure and the aging woman: mothers and daughters.
Laitman CJ
Curr Womens Health Rep; 2002 Oct; 2(5):390-3. PubMed ID: 12215312
[TBL] [Abstract][Full Text] [Related]
10. Clear cell renal carcinoma in a pregnant DES-exposed patient.
Mansi ML
J Am Osteopath Assoc; 1989 Jul; 89(7):929-32. PubMed ID: 2768009
[TBL] [Abstract][Full Text] [Related]
11. Antenatal exposure to DES: lessons learned...future concerns.
Rubin MM
Obstet Gynecol Surv; 2007 Aug; 62(8):548-55. PubMed ID: 17634156
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological studies of the effects of diethylstilboestrol.
Vessey MP
IARC Sci Publ; 1989; (96):335-48. PubMed ID: 2680951
[TBL] [Abstract][Full Text] [Related]
13. Genital clear cell adenocarcinoma.
Johnston GA; Jones HA
Int Surg; 1983; 68(3):257-61. PubMed ID: 6662641
[TBL] [Abstract][Full Text] [Related]
14. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol.
Newbold RR; McLachlan JA
Cancer Res; 1982 May; 42(5):2003-11. PubMed ID: 7066910
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero.
Boyd J; Takahashi H; Waggoner SE; Jones LA; Hajek RA; Wharton JT; Liu FS; Fujino T; Barrett JC; McLachlan JA
Cancer; 1996 Feb; 77(3):507-13. PubMed ID: 8630958
[TBL] [Abstract][Full Text] [Related]
16. Diethylstilbestrol exposure in utero: review of literature.
Glaze GM
J Am Osteopath Assoc; 1984 Feb; 83(6):435-8. PubMed ID: 6368486
[TBL] [Abstract][Full Text] [Related]
17. The effects in the human of diethylstilbestrol (DES) use during pregnancy.
Herbst AL
Princess Takamatsu Symp; 1987; 18():67-75. PubMed ID: 3506546
[TBL] [Abstract][Full Text] [Related]
18. Diethylstilbestrol and other sex hormones during pregnancy.
Herbst AL
Obstet Gynecol; 1981 Nov; 58(5 Suppl):35S-40S. PubMed ID: 7031540
[TBL] [Abstract][Full Text] [Related]
19. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update.
Melnick S; Cole P; Anderson D; Herbst A
N Engl J Med; 1987 Feb; 316(9):514-6. PubMed ID: 3807995
[TBL] [Abstract][Full Text] [Related]
20. Primary non-clear-cell adenocarcinomas of the vagina in older DES-exposed women.
DeMars LR; Van Le L; Huang I; Fowler WC
Gynecol Oncol; 1995 Sep; 58(3):389-92. PubMed ID: 7672708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
